Loading...
Loading...
Analysts at Pivotal Research initiated coverage on USANA Health Sciences
USNA with a Buy rating.
The target price for USANA Health Sciences is set to $100.
USANA Health Sciences shares have dropped 7.92% over the past 52 weeks, while the S&P 500 index has surged 8.14% in the same period.
USANA Health Sciences' shares surged 0.40% to close at $80.36 on Friday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in